INTRODUCTION
Diclofenac potassium is a faintly yellowish white to light beige, virtually odorless, slightly hygroscopic crystalline powder. It is freely soluble in methanol, soluble in ethanol and water, and practically insoluble in chloroform and in dilute acid. The n-octanol/water partition coefficient is 13.4 at pH 7.4 and 1545 at pH 5.2. It has a single dissociation constant (pKa) of 4.0 ± 0.2 at 25°C in water [1] . Diclofenac potassium (Diclo-K) is a substituted phenyl-acetic acid derivative and widely used in the management of many inflammatory conditions [2] [3] . It also has analgesic and antipyretic actions. In spite of its pharmacological importance, relatively few studies are known to explain analytical quantification of diclofenac potassium in human plasma.
HPLC is a powerful tool for analyzing small analytes such as drugs in biological samples. However, analysis of analytes present in matrices such as plasma requires welldesigned sample preparation procedures such as protein precipitation, centrifugation, extraction and filtration that can introduce experimental errors and ultimately reduce precision and accuracy of measurement [3] [4] . An attractive approach would be to reduce the number of treatments in sample preparation procedure in order to minimize human and non-human errors. Reverse phase high performance liquid chromatography (RP-HPLC), a bonded phase chromatographic technique, uses water as a base solvent. Separation based on solvent strength and selectivity also may be affected by column temperature and pH. In general, the more polar component (diclofenac potassium) elutes faster than the less polar one [4] . In the pH range 2 -8, RP-HPLC resolves polar components efficiently [5] .
The aim of this work was to develop a simple, accurate, reproducible and sensitive method for the determination of diclofenac potassium in human plasma using rapid, convenient and simple liquid-liquid extraction and reverse phase HPLC method based on UV-visible detection [6] .
EXPERIMENTAL Materials
All the reagents used were of analytical grade. Diclofenac potassium was donated by PDH Pharmaceuticals Pvt Ltd, Lahore, ketoprofen by Sanofi Aventis Limited Karachi, Pakistan. Acetonitrile, methanol, ammonium acetate, triethylamine (TEA), sodium chloride, sulphuric acid and ortho-phosphoric acid 85 %v/v were obtained from Merck, Germany. HPLC grade water was obtained using a water distillation appratus (model, IM-100, Irmeco GmbH, Germany) and filtered, prior to use, through a vaccum filter assembly (Sartorius Goettingen, Germany) containing a cellulose acetate filter of 0.45µm pore size.
Instrumentation
HPLC (Perkin Elmer, Series 200, USA) with TCNav software, consisted of a binary pump solvent delivery system, an ultraviolet-visible (UV-Vis) variable wavelength detector, integrator NCI 900 was used. Samples were introduced into a Rheodyne 20 µL fixed-loop injector with a 50 µL glass syringe. Chromatographic separation was performed on a 5 µm particle size, 4.0 mm x 250 mm ODS Hypersil C18 stainless steel analytical column (Thermo Electron Corporation, UK). All solvents were degassed with a sonicator (Elma D78224, Germany) and pH were checked with a pH meter (Inolab, Series WTW, Germany) prior to use.
Preparation of mobile phase
To prepare 1 L of mobile phase, 500 mL of HPLC grade water was added to 500 mL of acetonitrile. Freshly prepared 0.1 M ammonium acetate (2 mL) and 100 µL TEA were added, consecutively, to the mixture. This order of mixing was strictly maintained throughout the study. The pH of the mobile phase was adjusted to 3.0 using orthophosphoric acid. The mobile phase was prepared daily and was not recycled during use.
Preparation of stock solution
Stock solution of diclofenac potassium was freshly prepared in 50% (v/v) aqueous acetonitrile to give a final concentration of 1 mg mL -1 (1000 µg 1000 µL ) and then further diluted to 250 µg mL -1 .
Spiked plasma method
The modified method [7, 8] involved acidifying 500 µL of plasma sample, containing 20 µL of Diclo-K and 50 µL of 250 µg mL -1 ketoprofen (I.S), with 500 µL of 1.74 M sulphuric acid. The plasma sample was modified with 20 µL of 3M NaCl and vortexed for 1 min [9, 10] . Acetonitrile (500 µL) was added and vortexed for 30 s. The order of mixing was maintained throughout the study. The resultant mixture was centrifuged at 3000 rpm for 10 min. The supernatant was separated in Eppendrof tubes. An aliquot (20 µL) of this supernatant was chromatographed.
Preparation of standard curve
A standard curve was prepared by spiking 500 µL plasma samples with 20 µL of one of the working solutions prepared above to produce calibration curve points equivalent to 0.05, 0.1, 0.25, 0.5, 1.0, 2.5, 5.0, 10, 20 and 40 µg mL -1 of diclofenac potassium.
Each suppernatant (20 µL) was injected with a 50 µL HPLC syringe and absorbance was taken at 276 nm. All the tests were performed in triplicate.
Extraction recovery
Recovery was determined by comparing the values of the peak area of spiked plasma and its relevant solution using Eq 1.
% Recovery = (Diclo-K ext /I.S)/ (Diclo-K nonext /I.S) x 100 ……………………………… (1) where Diclo-K ext /I.S = area ratio of extracted diclofenac potassium to ketoprofen, and Diclo-K non-ext /I.S = area ratio of solution of diclofenac potassium to ketoprofen
Method validation
The method was validated in accordance with European Medicines Evaluation Agency (EMEA) guidelines [11] on validation of bioanalytical methods. General tests performed were: recovery, accuracy, precision, reproducibility, linearity, specificity, limit of detection and quantification and ruggedness [12] [13] [14] .
Specificity (Selectivity)
To evaluate the specificity of the developed method, placebo and appropriate test sample (spiked plasma) were run in triplicate on HPLC the preset conditions and the results compared, statistically.
Linearity of the calibration line/range
The calibration plots for the analyte in plasma were prepared by spiking drug-free plasma with standard stock solutions to yield concentrations of 0.25 -40.0 µg mL -1 for diclofenac potassium. The linearity among nominal concentrations and observed peak area ratio was calculated by least squares method using regression line.
Accuracy and bias
Accuracy (%) = (CObs. Mean/ CNom) x 100 ……… (2) Experimental errors in the test were determined using the values of standard deviation (SD) and standard error mean (SEM) while the accuracy of the results in consecutive and non-consecutive fashion was defined by values of the 95 % confidence of interval (95% CI) at lower (L) and upper limits (U).
Precision
It was desirable to have an injection precision in terms of relative standard deviation (RSD). The precision of the method was defined with the existence of the results in range, i.e., 0 -10 [15] [16] [17] [18] . The results of the developed method were validated by inter-day precision after one month.
Limits of detection (LOD) and Quantification (LOQ)
The LOD for extracted diclofenac potassium from spiked plasma sample was measured at signal to noise (S/N) ratio of 2:1 with precision and accuracy. To determine LOD and LOQ, the plasma samples were chromatographed with descending order of the spiked concentrations of analyte. Based on the relative standard deviation (RSD) obtained, the LOQ was subsequently validated by replicate analysis (≥≥ 6) of samples prepared around this concentration. The LOD was taken as 0. 
RESULTS
First, this method was implemented for the extraction of diclofenac potassium. Thereafter, it was applied to extract ketoprofen as well. The peak areas were noted for each concentration under preset conditions shown in Table 1 . The recovery values (mean ± SEM) of diclofenac potassium and ketoprofen were 98.09 ± 5.42 and 104.5 ± 6.76, respectively. Bias of the results are shown in Table 2 . The selectivity of the developed method was good based on the fact that there was no interfering peak in the chromatograms (not shown) at the retention time of diclofenac potassium. Both drugs (diclofenac potassium and ketoprofen, i.e., IS) were separated sufficiently at 14 ± 1 min and 7 ± 1 min, respectively. The calibration equation (y = 20132x -1740, with R 2 = 0.9991) indicated a high degree of linearity as well as specificity of the method. At lower concentrations of diclofenac potassium, i.e., 0.25 and 0.5 µg mL -1 , % recovery of the sample was in a wider range thus indicating lower accuracy of the results due to sensitivity of the HPLC method at lower concentrations as shown in the Table 3 .
It was observed that the accuracy of the results for developed method was better for higher concentrations than for lower concentrations of the drug as shown in Table  3 . Precision was considered with intra-and inter-day performance of the developed method, as shown in Tables 4 and 5 .
All the results were within the defined range except for the lower concentration, i.e., 0.25 µg mL -1 in intra-day study. Inter-day statistics also showed the stability of the extracted sample at -20 ºC. The LOD was 0.05 µg mL -1 . The quantifiable concentration for diclofenac potassium in biological sample was 0.25 µg mL -1 under the stated HPLC conditions. 
DISCUSSION
From the recovery data, the developed method is suitable for diclofenac potassium and ketoprofen. There were neither overlapping nor interfering peaks at the retention times of the drugs so it was presumed that all the plasma proteins precipitated efficiently during the plasma treatment process. Thus this reduced sample processing time. Although there was variation in bias this may be reduced by treating the samples more carefully during the extraction process. The mobile phase used in this work was so simple and economical; so also was the extraction procedure which was short in duration. Thus, the chances of column damage and degree of human errors were minimal. Recovery of both drugs (diclofenac potassium and ketoprofen) in the different assays under the same pre-set conditions may indicate the suitability of the developed method for NSAIDs and its analogs. Regarding the stability of the drug in human plasma, the intra-and inter day statistics were favourable. The use of sulphuric acid and sodium chloride was critical to the effectiveness of the extraction procedure.
Precautionary measures
During sample pretreatment, the following precautionary measures must be followed: (a) Molar solutions of NaCl and H 2 SO 4 that 24-h old must not be used. It was found that old solutions did not precipitate plasma proteins efficiently. 
CONCLUSION
The proposed method may be applied to routine analysis of diclofenac potassium due to its high sensitivity, specificity, repeatability, reproducibility, robustness and ruggedness. The method is also applicable to ketoprofen which was used as the internal standard (IS). The extraction procedure is especially timesaving for in vivo analysis of NSAIDs.
